ACP
Ashfield Capital Partners’s Gilead Sciences GILD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-2,982
| Closed | -$230K | – | 239 |
|
|
2018
Q3 | $230K | Buy |
+2,982
| New | +$230K | 0.03% | 237 |
|
|
2018
Q2 | – | Sell |
-2,820
| Closed | -$213K | – | 251 |
|
|
2018
Q1 | $213K | Hold |
2,820
| – | – | 0.03% | 241 |
|
|
2017
Q4 | $202K | Hold |
2,820
| – | – | 0.03% | 249 |
|
|
2017
Q3 | $228K | Sell |
2,820
-715
| -20% | -$57.8K | 0.03% | 234 |
|
|
2017
Q2 | $250K | Sell |
3,535
-26,227
| -88% | -$1.85M | 0.03% | 230 |
|
|
2017
Q1 | $2.02M | Sell |
29,762
-32,429
| -52% | -$2.2M | 0.28% | 96 |
|
|
2016
Q4 | $4.45M | Sell |
62,191
-40,880
| -40% | -$2.93M | 0.44% | 70 |
|
|
2016
Q3 | $8.16M | Sell |
103,071
-36,232
| -26% | -$2.87M | 0.67% | 50 |
|
|
2016
Q2 | $11.6M | Sell |
139,303
-37,221
| -21% | -$3.11M | 0.93% | 40 |
|
|
2016
Q1 | $16.2M | Sell |
176,524
-1,694
| -1% | -$156K | 1.17% | 25 |
|
|
2015
Q4 | $18M | Sell |
178,218
-91,077
| -34% | -$9.22M | 1.23% | 27 |
|
|
2015
Q3 | $26.4M | Buy |
269,295
+178,410
| +196% | +$17.5M | 1.7% | 16 |
|
|
2015
Q2 | $10.6M | Buy |
90,885
+15,732
| +21% | +$1.84M | 0.58% | 51 |
|
|
2015
Q1 | $7.38M | Buy |
75,153
+13,863
| +23% | +$1.36M | 0.39% | 61 |
|
|
2014
Q4 | $5.78M | Sell |
61,290
-289
| -0.5% | -$27.2K | 0.28% | 69 |
|
|
2014
Q3 | $6.56M | Buy |
61,579
+768
| +1% | +$81.8K | 0.32% | 69 |
|
|
2014
Q2 | $5.04M | Buy |
60,811
+881
| +1% | +$73K | 0.24% | 77 |
|
|
2014
Q1 | $4.25M | Buy |
59,930
+2,393
| +4% | +$170K | 0.2% | 80 |
|
|
2013
Q4 | $4.32M | Buy |
57,537
+19,528
| +51% | +$1.47M | 0.21% | 78 |
|
|
2013
Q3 | $2.39M | Buy |
38,009
+3,552
| +10% | +$223K | 0.12% | 99 |
|
|
2013
Q2 | $1.77M | Buy |
+34,457
| New | +$1.77M | 0.1% | 113 |
|